Cashew Nut (Anacardium occidentale)

Cashew nuts (Anacardium occidentale) contain anacardic acids, cardols, and unsaturated fatty acids—particularly oleic acid—that modulate inflammatory pathways and intestinal barrier integrity. These bioactive compounds inhibit pro-inflammatory cytokine signaling and support tight-junction protein expression, contributing to measurable reductions in body fat, waist circumference, and systemic inflammation.

Origin & History

Cashew nut derives from the kidney-shaped seed of Anacardium occidentale L., a tree native to northeastern Brazil but now cultivated in tropical regions worldwide, including India, Vietnam, and Africa. The edible nut is obtained by roasting or steaming the seed to remove the caustic shell containing urushiol, followed by shelling and drying.

Historical & Cultural Context

The research dossier lacks historical traditional medicine data for Anacardium occidentale nuts. No mentions of traditional systems like Ayurveda or TCM were found in the clinical sources.

Health Benefits

• Reduces body fat and waist circumference in overweight adults when combined with calorie restriction (RCT, n=68, PMID: 38988854) - moderate evidence • Improves intestinal permeability and reduces inflammatory markers like zonulin and CRP (RCT, n=64, PMID: 39335845) - moderate evidence • Decreases triglycerides and LDL cholesterol levels during weight loss programs (RCT, n=68, PMID: 38988854) - moderate evidence • Reduces oxidative stress markers in adolescents with obesity (RCT, PMID: 39862524) - moderate evidence • Enables desensitization in cashew-allergic children through oral immunotherapy with 91% success rate (n=24, PMID: 39570923) - preliminary evidence

How It Works

Anacardic acids in cashew nuts inhibit NF-κB signaling, reducing downstream production of TNF-α, IL-6, and CRP, which attenuates systemic inflammation. Oleic acid activates PPAR-α and PPAR-γ nuclear receptors, promoting fatty acid oxidation and improving lipid metabolism, which contributes to reductions in visceral adiposity. Additionally, cashew bioactives appear to upregulate tight-junction proteins such as occludin and zonulin regulation, strengthening intestinal epithelial barrier function and reducing gut permeability-driven endotoxemia.

Scientific Research

Clinical evidence comes from small randomized controlled trials primarily in overweight/obese adults (n=64-68) testing 30g/day cashew nuts or 30mL/day cashew oil during 8-week energy restriction (PMIDs: 38988854, 39335845). Additional studies include oral immunotherapy trials in cashew-allergic children showing 91% desensitization rates (PMID: 39570923) and infant introduction studies demonstrating safety from 6 months (PMID: 37366200).

Clinical Summary

A randomized controlled trial (n=68, PMID: 38988854) demonstrated that cashew nut consumption combined with calorie restriction significantly reduced body fat percentage and waist circumference in overweight adults, constituting moderate-quality evidence. A separate RCT (n=64, PMID: 39335845) found improvements in intestinal permeability markers, including statistically significant reductions in zonulin and C-reactive protein, also rated as moderate evidence. Overall, the clinical evidence base is promising but limited by relatively small sample sizes and short study durations, and most trials have not been independently replicated at scale. Larger, longer-duration trials are needed to confirm dose-response relationships and long-term cardiometabolic outcomes.

Nutritional Profile

Cashew nuts (raw, per 100g): Calories: 553 kcal. Macronutrients: Fat 43.8g (primarily monounsaturated oleic acid ~23.8g, polyunsaturated linoleic acid ~7.7g, saturated fat ~7.8g predominantly palmitic and stearic acids), Protein 18.2g (rich in arginine, leucine, lysine, and glutamic acid; relatively complete amino acid profile), Carbohydrates 30.2g (Net carbs ~27.3g, Dietary fiber 3.3g). Key Micronutrients: Copper 2.2mg (244% DV - exceptionally high, important for enzymatic reactions), Magnesium 292mg (69% DV - among highest of tree nuts), Manganese 1.66mg (72% DV), Phosphorus 593mg (47% DV), Zinc 5.78mg (53% DV), Iron 6.68mg (37% DV - notably high for a plant source, though bioavailability limited by phytates ~1,866mg phytic acid/100g), Selenium 19.9mcg (36% DV), Thiamine (B1) 0.42mg (35% DV), Vitamin K1 34.1mcg (28% DV), Vitamin B6 0.42mg (25% DV), Folate 25mcg (6% DV). Bioactive Compounds: Anacardic acids (alkylsalicylates, ~350mg/100g in raw form - antimicrobial, anti-inflammatory; significantly reduced by roasting), Cardanol and Cardol (phenolic lipids in cashew nut shell liquid - CNSL - minimal in edible kernel), Proanthocyanidins ~158mg/100g (condensed tannins with antioxidant activity), Tocopherols primarily gamma-tocopherol ~5.31mg/100g (Vitamin E activity), Phytosterols ~150mg/100g (predominantly beta-sitosterol ~114mg, campesterol ~22mg - contribute to LDL reduction), Carotenoids: trace lutein and zeaxanthin (~22mcg/100g). Bioavailability Notes: Phytic acid content (~1.87g/100g) reduces absorption of iron, zinc, and magnesium by 20-50%; soaking or roasting can reduce phytate levels by 15-30%. Fat matrix enhances absorption of fat-soluble compounds. Magnesium bioavailability estimated at ~40-50% of listed content. Protein digestibility-corrected amino acid score (PDCAAS) approximately 0.73, slightly lower than animal proteins but among higher plant sources. Roasting at high temperatures (>150°C) reduces anacardic acid content by up to 70% and may generate small amounts of acrylamide.

Preparation & Dosage

Clinically studied doses include: Whole nuts - 30g/day (approximately 1 oz) for 8 weeks; Cashew oil - 30mL/day (approximately 2 tablespoons) for 8 weeks; For allergy desensitization - gradual up-dosing to 1000-1200mg cashew protein maintenance dose over 12-60 weeks. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Almonds, walnuts, omega-3 fatty acids, probiotics, fiber supplements

Safety & Interactions

Cashew nuts are a top-8 allergen and can trigger IgE-mediated anaphylaxis in sensitized individuals; cross-reactivity with other tree nuts such as pistachio is well-documented due to shared vicilin proteins. Their high oxalate content may increase kidney stone risk in individuals predisposed to calcium oxalate nephrolithiasis, and high intake should be avoided in those with a history of renal stones. No significant drug interactions are firmly established at typical dietary doses, though the magnesium content could theoretically potentiate antihypertensive medications in large quantities. Cashew consumption is generally considered safe during pregnancy at normal dietary amounts, but concentrated extracts or supplements lack sufficient safety data for pregnant or lactating women.